, Volume 14, Issue 2, pp 75–87 | Cite as

Lactic acidosis in biguanide-treated diabetics

A review of 330 cases
  • D. Luft
  • R. M. Schmülling
  • M. Eggstein


The paper presents an analysis of clinical symptoms, signs and laboratory data of 330 diabetic patients who developed lactic acidosis after having been treated with biguanides (phenformin, buformin, metformin). From the review of the literature an attempt is made to find special features that predisposed patients to develop lactic acidosis such as accompanying illnesses and additional medications, to describe the course of illness and also the factors that influenced the prognosis. Of the patients that developed lactic acidosis 50.3% died. These patients were older, they suffered more frequently from cardiovascular shock, their acidosis was more severe, the whole blood lactate concentration was higher, and the degree of renal insufficiency was more advanced. From our observations we conclude that the treatment of diabetes mellitus with biguanides should be reserved for specially selected patients.

Key words

Diabetes mellitus phenformin buformin metformin lactic acidosis adverse drug effects 


  1. 1.
    Watanabe, C.K.: Studies in the metabolic changes induced by administration of guanidine bases. I. Influence of injected guanidine hydrochloride upon blood sugar content. J. Biol. Chem.33, 253–265 (1918)Google Scholar
  2. 2.
    Krall, L.P., Camerini-Davalos, R.: Early clinical evaluation of a new oral non-sulfonylurea hypoglycemic agent. Proc. Soc. Exp. Biol. Med.95, 345–347 (1957)PubMedGoogle Scholar
  3. 3.
    Pomeranze, J., Fujiy, H., Mouratoff, G.T.: Clinical report of a new hypoglycemic agent. Proc. Soc. Exp. Biol. Med.95, 193–194(1957)PubMedGoogle Scholar
  4. 4.
    Ungar, G., Freedman, L., Shapiro, S.L.: Pharmacological studies of a new oral hypoglycemic drug. Proc. Soc. Exp. Biol. Med.95, 190–192 (1957)PubMedGoogle Scholar
  5. 5.
    Williams, R.H., Typerghein, J.M., Hyde, P.M., Nielsen, R.L.: Studies related to the hypoglycemic action of phenethyldiguanide. Metabolism6, 311–319 (1957)PubMedGoogle Scholar
  6. 6.
    Walker, R.S., Linton, A.L.: Phenethyldiguanide: A dangerous side-effect. Br. Med. J.1959 II, 1005–1006Google Scholar
  7. 7.
    Sadow, H.S.: This question of lactic acidosis. Postgrad. Med. J.45 (Suppl.), 30–35 (1969)PubMedGoogle Scholar
  8. 8.
    Catellier, C., Fraser, E., Ayotte-Ferron, L., Savoie, J.-Y.: Plasma phenformin levels following a standard therapeutic dose in diabetics. Diabetes25, 357 (1976)Google Scholar
  9. 9.
    Hrstka, V., Schmidt, F.H.: Die radioimmunologische Bestimmung von Phenformin in biologischen Flüssigkeiten. Vortrag Nr.25. 11. Kongreß der Deutschen Diabetesgesellschaft, Braunlage 1976Google Scholar
  10. 10.
    Ötting, F., Berger, W., Thomas, T., Talke, H.: Elimination von Biguaniden bei eingeschränkter Nierenfunktion, Vortrag Nr. 41. 11. Kongreß der Deutschen Diabetesgesellschaft, Braunlage 1976Google Scholar
  11. 11.
    Karch, F.E., Lasagna, L.: Evaluating adverse drug reactions. Adverse Drug Reaction Bull.59, 204–207 (1976)Google Scholar
  12. 12.
    Oliva, P.B.: Lactic acidosis. Am. J. Med.48, 208–225 (1970)Google Scholar
  13. 13.
    Woods, H.F.: Some aspects of lactic acidosis. Br. J. Hosp. Med.11, 668–676 (1971)Google Scholar
  14. 14.
    Mascetti, R., Mascetti, P.: Sull'acidosi lattica da biguanidi. Minerva Med.63, 3930–3938 (1972)PubMedGoogle Scholar
  15. 15.
    Hermann, L.S.: Biguanides and lactate metabolism: a review. Dan. Med. Bull.20, 65–79 (1973)PubMedGoogle Scholar
  16. 16.
    Assan, R., Heuclin, C., Girard, J.R., Attali, J.R.: Acidose lactique induite par les biguanides. Nouv. Presse Med.5, 247–249 (1976)PubMedGoogle Scholar
  17. 17.
    Cohen, R.D., Woods, H.F.: Clinical and biochemical aspects of lactic acidosis. Oxford, London, Edinburgh, Melbourne: Blackwell Scientific Publications 1976Google Scholar
  18. 18.
    Harken, A.H.: Lactic acidosis. Surg. Gynecol. Obstet.142, 593–606 (1976)PubMedGoogle Scholar
  19. 19.
    Huckabee, W.E.: Abnormal resting blood lactate. I. The significance of hyperlactatemia in hospitalized patients. Am. J. Med.30, 833–839 (1961)Google Scholar
  20. 20.
    Huckabee, W.E.: Abnormal resting blood lactate. II. Lactic acidosis. Am. J. Med.30, 840–848 (1961)PubMedGoogle Scholar
  21. 21.
    Tranquada, R.E., Grant, W.J., Peterson, C.R.: Lactic acidosis. Arch. Intern. Med.117, 192–202 (1966)PubMedGoogle Scholar
  22. 22.
    Alberti, K.G.M.M., Corbett, J., Hockaday, T.D.R., Williamson, D.H.: Lactic acidosis. Br. Med. J.1971 1, 47–48 Google Scholar
  23. 23.
    Alling, B., Steen, B.: Analyser av mjölksyra och acetättiksyra i artärblod vid mjölksyraacidos hos fenforminbehandlad diabetiker. Lakartidningen67, 4914–4916 (1970)PubMedGoogle Scholar
  24. 24.
    Althoff, P.-H., Fassbinder, W., Neubauer, M., Koch, K.M., Schöffling, K.: Lactatazidose —Hämodialyse, Dialyse von Lactat und Biguaniden, Vortrag Nr. 1. 10. Kongreß der Deutschen Diabetesgesellschaft, Ulm 1975Google Scholar
  25. 25.
    Assan, R., Heuclin, C., Ganeval, D., Bismuth, Ch., George, J., Girard, J.R.: Metformin-induced lactic acidosis in the presence of acute renal failure. Diabetologia13, 211–217 (1977)PubMedGoogle Scholar
  26. 26.
    Assan, R., Heuclin, C., Girard, J.R., LeMaire, F., Attali, J.R.: Phenformin-induced lactic acidosis in diabetic patients. Diabetes24, 791–800 (1975)PubMedGoogle Scholar
  27. 27.
    Assan, R., Souchal, B., Aubert, Ph., Tchobroutsky, G., Dérot, M.: Comas métaboliques non acido-cétosiques chez des diabétiques. Presse Med.77, 787–789 (1969)PubMedGoogle Scholar
  28. 28.
    Auzépy, Ph., Masliah-Planchon, R., Baulon, A., Lemonnier, A., Deparis, M.: Acidose lactique. Importance prognostique du diagnostic précoce. Ann. Med. Interne (Paris)122, 13–20 (1971)Google Scholar
  29. 29.
    Azerad, E., Lubetzky, J., Duprey, J., Friedler, D.: L'acidose lactique chez les diabétiques. A propos de sept observations. Presse Med.77, 1705–1708 (1969)PubMedGoogle Scholar
  30. 30.
    Azerad, E., Lubetzky, L., Duprey, J., Friedler, D., Weiss, A.M.: Six cas d'acidose lactique chez les diabétiques. Le Diabète (Le Raincy)16, 87–95 (1968)Google Scholar
  31. 31.
    Ball, J.E., Lupin, A.M., Mary, C.C., Elliot, W.: Complications of therapy with oral hypoglycémic agents. J. La. State Med. Soc.116, 353–356 (1964)PubMedGoogle Scholar
  32. 32.
    Ball, S., Woods, H.F., Alberti, K.G.M.M.: Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformin-treated diabetic patient. Br. Med. J.1974 IV, 699–700Google Scholar
  33. 33.
    Bengtsson, K., Karlberg, B., Lindgren, S.: Lactic acidosis in phenformin-treated diabetics. Acta Med. Scand.191, 203–208 (1972)PubMedGoogle Scholar
  34. 34.
    Berger, W., Göschke, H., Ohnhaus, E.: Problèmes d'actualité concernant le mécanisme d'action des biguanides. Journ. Annu. Diabetol. Hotel Dieu16, 239–258 (1975)Google Scholar
  35. 35.
    Berger, W., Mehnert-Aner, S., Mülly, K., Heierli, Ch., Ritz, R.: Zehn Fälle von Lactatazidose unter Biguanidtherapie (Buformin und Phenformin). Schweiz. Med. Wochenschr.106, 1830–1834 (1976)PubMedGoogle Scholar
  36. 36.
    Bernier, G.M., Miller, M., Springate, C.S.: Lactic acidosis and phenformin hydrochloride. JAMA184, 43–46 (1963)PubMedGoogle Scholar
  37. 37.
    Bernier, G. M., Springate, C. S., Miller, M.: Lactic acidosis and phenethylbiguanide. 22nd Meeting Am. Diab. Assoc., Chicago 1962Google Scholar
  38. 38.
    Bertrand, C.M.: Les hyperlactatémies pathologiques au cours des traitements par la phenformine. Presse Med.78, 13–14 (1970)PubMedGoogle Scholar
  39. 39.
    Bierbach, H., Busch, S.: Letale Laktacidose unter Biguanidtherapie. Bericht über drei Fälle. Inn. Med.4, 217–221 (1977)Google Scholar
  40. 40.
    Bingle, J.P., Storey, G.W., Winter, J.M.: Fatal self-poisoning with phenformin. Br. Med. J.1970 III, 752Google Scholar
  41. 41.
    Bismuth, Ch., Gaultier, M., Conso, F., Heuclin, C., Assan, R.: Acidose lactique induite par l'ingestion excessive de metformine. Nouv. Presse Med.5, 261–263 (1976)PubMedGoogle Scholar
  42. 42.
    Bismuth, C., Gaultier, M., Conso, F., Assan, R., Heuclin, C.: Acidose lactique induite par l'ingestion excessive de metformin. Eur. J. Toxicol. Environ. Hyg.9, 55–57 (1976)PubMedGoogle Scholar
  43. 43.
    Bjordahl, R.: Lactic acidosis in association with phenformin therapy: Report of two cases. J. Am. Osteopath. Assoc.75, 1061–1065 (1976)PubMedGoogle Scholar
  44. 44.
    Blumenthal, S.A., Streeten, D.H.P.: Lactic acidosis in diabetics: Evidence for a primary etiologic role of phenformin. Diabetes24, 428 (1975)Google Scholar
  45. 45.
    Blumenthal, S.A., Streeten, D.H.P.: Phenformin-related lactic acidosis in a thirty-year-old man. Ann. Intern. Med.84, 55–56 (1976)Google Scholar
  46. 46.
    Böttiger, L.E.: Mjölksyraacidos och biguanider — en översikt. Lakartidningen70, 3463–3464 (1973)PubMedGoogle Scholar
  47. 47.
    Bourdais, A.: L'épuration extrarénale dans les acidoses lactiques des diabétiques traités par la phenformine. Nouv. Presse Med.2, 1273–1276 (1973)PubMedGoogle Scholar
  48. 48.
    Bourdais, A., Legall, F., Mathieu, H., Joly, R.: Traitement par hémodialyse et alcalinisation des acidoses lactiques des diabétiques recevant des biguanides. Soc. Med. Chir. Hop. Form. Sanit. Armées3, 287–296 (1971)Google Scholar
  49. 49.
    Brach, B.B., Blackard, W., Rothschild, H.: A review of deaths due to suspected lactic acidosis at a large metropolitan hospital. South. Med. J.68, 202–205 (1975)PubMedGoogle Scholar
  50. 50.
    Brubakk, O., Hopen, G.: Melkesyreacidose behandlet med glukose og insulin. Tidsskr. Nor. Laegeforen.95, 1412–1413 (1975)PubMedGoogle Scholar
  51. 51.
    Bryant, S., Bartley, P.C.: Phenformin-induced lactic acidosis in diabetes mellitus. Med. J. Aust.1972 I, 1041–1044Google Scholar
  52. 52.
    Buess, H.J., Mihatsch, M.J., Wunderlich, P., Berger, W.: Laktatazidose bei Diabetes mellitus. Schweiz. Rundschau Med. (Praxis)65, 406–413 (1976)Google Scholar
  53. 53.
    Butt, H., Reitinger, J.: Lactatacidose und Biguanidtherapie. Med. Klin.72, 708–711 (1977)PubMedGoogle Scholar
  54. 54.
    Christiansen, J., Öberg, T.: Två fall av misstänkt laktatacidos i samband med fenforminbehandlad diabetes mellitus. Lakartidningen69, 5425–5427 (1972)PubMedGoogle Scholar
  55. 55.
    Clavadetscher, P., Bischof, P., Wegmann, T.: Lactat-Acidose nach Buformin-Medikation. Dtsch. Med. Wochenschr.101, 238–241 (1976)PubMedGoogle Scholar
  56. 56.
    Cleaver, T., Carretta, R.: Lactic acidosis with phenformin therapy. Calif. Med.117, 14–19 (1972)PubMedGoogle Scholar
  57. 57.
    Cohen, R.D., Ward, J.D., Brain, A.J.S., Murray, C.R., Savage, T.M., Iles, R.A.: The relation between phenformin therapy and lactic acidosis. Diabetologia9, 43–46 (1973)PubMedGoogle Scholar
  58. 58.
    Conlay, L.A., Loewenstein, J.E.: Phenformin and lactic acidosis. JAMA235, 1575–1578 (1976)PubMedGoogle Scholar
  59. 59.
    Conlay, L.A., Matin, S.B., Loewenstein, J.E.: Serum phenformin concentrations in patients with phenformin-associated lactic acidosis. Diabetes25, 359 (1976)Google Scholar
  60. 60.
    Coodley, E., Derasse, J., Carver, J.: Phenformin and pancreatitis. Letter to the editor. Ann. Intern. Med.78, 307 (1973)PubMedGoogle Scholar
  61. 61.
    Gurtes, J.P., Mono, B., Feuillu, A., Cartier, F.: Un cas d'hyper-lactatémie avec acidose, chez un diabétique traité par la phenformine. Eur. J. Toxicol. Environ. Hyg.5, 361–365 (1972)Google Scholar
  62. 62.
    Davidson, M.B., Bozarth, W.R., Challoner, D.R., Goodner, C.J.: Phenformin, hypoglycemia and lactic acidosis. N. Engl. J. Med.285, 886–888 (1966)Google Scholar
  63. 63.
    Debry, G., Laurent, J.: Acidose lactique et diabète sucré. Helv. Med. Acta35, 433–447 (1969/70)Google Scholar
  64. 64.
    Dembo, A.J., Marliss, E.B., Halperin, M.L.: The role of insulin deficiency in the pathogenesis of phenformin-associated lactic acidosis. Diabetes23, 370 (1974)Google Scholar
  65. 65.
    Dembo, A.J., Marliss, E.B., Halperin, M.L.: Insulin therapy in phenformin-associated lactic acidosis. Diabetes24, 28–35 (1975)PubMedGoogle Scholar
  66. 66.
    Dobson, H.L.: Attempted suicide with phenformin. Diabetes14, 811–812 (1965)PubMedGoogle Scholar
  67. 67.
    Duwoos, H., Bertrand, C.M., Husson, A., Cramer, J., Tayot, J.: Hyperlactatémie réversible induite par la phenformine avec asthénie musculaire et signes cardio-respiratoires. Presse Med.78, 23–26 (1970)PubMedGoogle Scholar
  68. 68.
    Edwards, J.C.W.: Phenformin and lactic acidosis. Br. Med. J.1976 I, 584Google Scholar
  69. 69.
    Ewy, G.A., Pabico, R.C., Maher, J.F., Mintz, D.H.: Lactate acidosis associated with phenformin therapy and localized tissue hypoxia. Ann. Intern. Med.59, 878–883 (1963)PubMedGoogle Scholar
  70. 70.
    Fulop. M., Hoberman, H.D.: Phenformin-associated metabolic acidosis. Diabetes25, 292–296 (1976)PubMedGoogle Scholar
  71. 71.
    Fulop, M., Hoberman, H.D., Rascoff, J.H., Bonheim, N.A., Dreyer, N.P., Tannenbaum, H.: Lactic acidosis in diabetic patients. Arch. Intern. Med.136, 987–990 (1976)PubMedGoogle Scholar
  72. 72.
    Futral, J., Anton, N.: Phenformin and lactic acidosis. Ariz. Med.28, 290–291 (1971)PubMedGoogle Scholar
  73. 73.
    Gale, E.A. M., Tattersall, R.B.: Can phenformin-induced lactic acidosis be prevented? Br. Med. J.1976 II, 972–975Google Scholar
  74. 74.
    Gmeiner, R., Hammerle, P.: Laktatazidose bei mit Phenformin behandeltem Diabetes mellitus mit tödlichem Ausgang. Wien. Klin. Wochenschr.86, 400–402 (1974)PubMedGoogle Scholar
  75. 75.
    Goldberg, L.D., Alterman, S.L.: Concurrent hypoglycemia and lactic acidosis in a diabetic treated with chlorpropamide and phenformin. South. Med. J.66, 190–192 (1973)PubMedGoogle Scholar
  76. 76.
    Gong, W.C., Kato, D.B.: Phenformin induced lactic acidosis: A case report and review of the literature. Drug Intel. Clin. Pharm.9, 236–240 (1975)Google Scholar
  77. 77.
    Gottlieb, A., Duberstein, J., Geller, A.: Phenformin acidosis. N. Engl. J. Med.267, 806–809 (1962)PubMedGoogle Scholar
  78. 78.
    Graeber, G.M., Marmor, B.M., Hendel, R.C., Gregg, R.O.: Pancreatitis and severe metabolic abnormalities due to phenformin therapy. Arch. Surg.111, 1014–1016 (1976)PubMedGoogle Scholar
  79. 79.
    Grivaux, M., Soulié, J., Diallo, A., Cosson, G., Chicandard, J.-F.: L'acidose lactique en réanimation. Ann. Med. Interne (Paris)122, 105–112(1971)Google Scholar
  80. 80.
    Grunst, J., Dobbelstein, H., Brinkmann, W., Edel, H.: Laktatazidose nach Phenylaethylbiguanid (Phenformin). Munch. Med. Wochenschr.114, 1942–1945 (1972)PubMedGoogle Scholar
  81. 81.
    Haas, T., Sailer, D., Flügel, H., Ruppin, H., Matzkies, F.: Laktat-Azidose nach 5tägiger Phenformin-Medikation. Fortschr. Med.94, 2074–2078 (1976)PubMedGoogle Scholar
  82. 82.
    Hansen, A.P., Braaten, J.T.: Maelkesyreacidose. En omtale af fem fatalt forlbende tilfaelde. Ugeskr. Laeger.130, 805–811 (1968)PubMedGoogle Scholar
  83. 83.
    Hayat, J.C.: Le traitement de l'acidose lactique chez le diabétique par la dialyse péritonéale à l'acétate de sodium. Nouv. Presse Med.2, 246 (1973)Google Scholar
  84. 84.
    Hayat, J.C.: The treatment of lactic acidosis in the diabetic patient by peritoneal dialysis using sodium acetate. A report of two cases. Diabetologia10, 485–487 (1974)PubMedGoogle Scholar
  85. 85.
    Hier-Madsen, K., Andersen, M.: Maelkesyreacidose ved fenforminbehandlet diabetes mellitus behandlet med peritonealdialyse uden bikarbonattilførsel. Ugeskr. Laeger.134, 1280–1281 (1972)PubMedGoogle Scholar
  86. 86.
    Isaacs, P.: Alcohol and phenformin in diabetes. Br. Med. J.1970 III, 773–774Google Scholar
  87. 87.
    Jensen, H.Ä.: Treatment of lactic acidosis with insulin and glucose. Dan. Med. Bull.20, 16–17 (1973)PubMedGoogle Scholar
  88. 88.
    Jensen, H.Ä., Hammer, A.: Maelkesyreacidose hos diabetiker i fenforminbehandling Nord. Med. 85, 469–471 (1971)Google Scholar
  89. 89.
    Johnson, H.K., Waterhouse, C.: Lactic acidosis and phenformin. Arch. Intern. Med.122, 367–370 (1968)PubMedGoogle Scholar
  90. 90.
    Karam, J., Matin, S., Levin, S., Forsham, P.H.: Circulating phenformin levels: Implications as to phenformin's therapeutic action. Diabetes23, 375 (1974)Google Scholar
  91. 91.
    Knatterud, G.L., Klimt, C.R., Osborne, R.K., Meinen, C.L., Martin, D.B., Hawkins, B.S.: A study of the effects of hyoglycemic agents on vascular complications in patients with adult-onset diabetes: V. Evaluation of phenformin therapy. Diabetes24 (Suppl. 1), 65–184 (1975)PubMedGoogle Scholar
  92. 92.
    Kristensen, O., Andersen, H.H.: Fenformininduseret maelkesyreacidose behandlet med glukose og insulin. Ugeskr. Laeger.136, 2458–2459 (1974)PubMedGoogle Scholar
  93. 93.
    Kristensen, O., Andersen, H.H., Jensen, J.B.: Glucose-insulin treatment of lactic acidosis in phenformin-treated diabetics. Acta Med. Scand.197, 463–465 (1975)PubMedGoogle Scholar
  94. 94.
    Kunz, F., Dienstl, F., Hörtnagl, H., Holzknecht, F., Lederer, B.: Lactatacidose und akute Verbrauchskoagulopathie bei Phenforminmedikation. Dtsch. Med. Wochenschr.100, 1288–1291 (1975)PubMedGoogle Scholar
  95. 95.
    Lacher, J., Lasagna, L.: Phenformin and lactic acidosis. Clin. Pharmacol. Ther.7, 477–481 (1966)PubMedGoogle Scholar
  96. 96.
    Larcan, A., Lambert, H.: L'acidose lactique, A propos de 42 observations collectées dans un service de réanimation. Journ. Annu. Diabetol. Hotel Dieu17, 99–133 (1976)Google Scholar
  97. 97.
    Lebacq, E.G., Tirzmalis, A.: Metformin and lactic acidosis. Lancet1972 I, 314–315Google Scholar
  98. 98.
    Levithan, A.A.: Phenformin and pancreatitis. Ann. Intern. Med.78, 306–307 (1973)Google Scholar
  99. 99.
    Lindgren, S.: Mjölksyraacidos vid behandling med fenformin. Lakartidningen66, 3705–3714 (1969)PubMedGoogle Scholar
  100. 100.
    Luft, D., Müller, P.H.: Laktazidose bei biguanidbehandelten Diabetikern. Med. Welt28 (NF), 378–383 (1977)PubMedGoogle Scholar
  101. 101.
    Luft, D., Müller, P.H., Eggstein, M.: unpublished observationGoogle Scholar
  102. 102.
    Ly, B.E., Gedde-Dahl, D.: Fenforminindusert metabolsk acidose. En kasuistik. Tidsskr. Nor. Laegeforen89, 1724–1726 (1969)Google Scholar
  103. 103.
    MacGregor, G.A., Poole-Wilson, P.A., Jones, N.F.: Phenformin and metabolic acidosis. Lancet1972 I, 69–71Google Scholar
  104. 104.
    Marliss, E.B., Aoki, T.T., Toews, C.J., Felig, P., Connon, J.J., Kyner, J., Huckabee, W.E., Cahill, G.F., jr.: Amino acid metabolism in lactic acidosis. Am. J. Med.52, 474–481 (1972)PubMedGoogle Scholar
  105. 105.
    Marliss, E.B., Ohman, J.L., jr., Aoki, T.T., Kozak, G.P.: Altered redox state obscuring ketoacidosis in diabetic patients with lactic acidosis. N. Engl. J. Med.283, 978–980 (1970)PubMedGoogle Scholar
  106. 106.
    Marowski, B.: Phenformin, Niereninsuffizienz und Lactatacidose. Ther. Ggw.113, 1706–1726 (1974)PubMedGoogle Scholar
  107. 107.
    Masliah-Planchon, R., Auzépy, Ph., Deparis, M.: L'acidose lactique des diabétiques traités par la phenformine. Eur. J. Toxicol. Environ. Hyg.5, 316–321 (1972)Google Scholar
  108. 108.
    Meignan, M., Lemaire, F., Rapin, M., Assan, R.: Choc cardiogénique avec hypothermie compliquant l'acidose lactique aiguë secondaire à la phenformine. Nouv. Presse Med.4, 1136–1138 (1975)Google Scholar
  109. 109.
    Mengis, C.L.: Lactic acid acidemia and phenformin. Rocky Mt. Med. J.61, 39–41 (1964)Google Scholar
  110. 110.
    Merceron, R.E., Raymond, J.-P., Andreassian, B., Klotz, H.P.: Guérison d'un coma par acidose lactique chez une diabétique traitée par la phenyl ethyl biguanide. Le Diabète (Le Raincy)20, 182–183 (1972)Google Scholar
  111. 111.
    Mestman, J.H., Pocock, D.S., Kirchner, A.: Lactic acidosis with recovery in diabetes mellitus on phenformin therapy. Calif. Med.111, 181–185 (1969)PubMedGoogle Scholar
  112. 112.
    Milisci, R.E., Decherd, J., McFadden, E.R., Strader, W.J., III, Nusynowitz, M.L.: Phenformin-induced lactic acidosis. Recovery with massive bicarbonate therapy and hemodialysis. Am. J. Med. Sci.265, 447–453 (1973)PubMedGoogle Scholar
  113. 113.
    Miller, M.: Side effects of the biguanide therapy and the problem of lactic acidosis. In: K. Oberdisse, H. Daweke, G. Michael (Hrsg.): 2nd. Internat. Biguanide Symposium, Düsseldorf, 1967, p 147–151. Stuttgart: G. Thieme Verlag 1968Google Scholar
  114. 114.
    Mirouze, J., Mion, Ch., Jullien, Ch., Beraud, J.-J.: Acidose lactique chez les diabétiques traités par la phenformine. Le Diabète (Le Raincy)20, 33–37 (1972)Google Scholar
  115. 115.
    Mirouze, J., Mion, Ch., Beraud, J.-J., Selam, J.-L.: Acidose lactique à l'occasion d'insuffisance rénale chez deux diabétiques traités par metformine. Nouv. Presse Med.5, 1004–1007 (1976)Google Scholar
  116. 116.
    Muller, A.J.: Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents. J. Am. Osteopath. Assoc.71, 1093–1097 (1972)PubMedGoogle Scholar
  117. 117.
    Neubauer, M., Althoff, P.-H., Fassbinder, W., Koch, M., Schöffling, K.: Zur Effektivität der Behandlung der Biguanid-induzierten Lactat-Azidose durch Hämodialyse, Vortrag Nr. 45. 12. Kongreß der Deutschen Diabetesgesellschaft, Homburg/Saar 1977Google Scholar
  118. 118.
    Oliva, P.B.: Phenformin and lactic acidosis. Report of a case and review of the literature. Med. Ann. DC38, 548–552 (1969)PubMedGoogle Scholar
  119. 119.
    Payne, J.R.: Clinically severe lactic acidosis with coma. Calif. Med.105, 281–284 (1966)PubMedGoogle Scholar
  120. 120.
    Phillipson, E.A., Sproule, B.J.: The clinical significance of elevated blood lactate. Can. Med. Assoc. J.92, 1334–1338 (1965)PubMedGoogle Scholar
  121. 121.
    Pi-non-Selles, F., Gudin-Herrero, J.: Acidosis lactica de rapida evolucion en diabetico tratado con fenformina. Rev. Clin. Esp.128, 535–538 (1973)PubMedGoogle Scholar
  122. 122.
    Proctor, D.W., Stowers, J.M.: Fatal lactic acidosis after an overdose of phenformin. Br. Med. J.1967 IV, 216Google Scholar
  123. 123.
    Reitan, J.A., Stephens, R.B., Warpinski, M.A.: Phenformin-induced lactic acidosis and anesthesia. Anesthesiology39, 562–564 (1973)PubMedGoogle Scholar
  124. 124.
    Riedler, G.F., Keusch, G., Schmid, M.: Knochenmarktoxizität, Laktatazidose und disseminierte intravasale Gerinnung nach Phenforminmedikation. Schweiz. Med. Wochenschr.104, 1160–1166 (1974)PubMedGoogle Scholar
  125. 125.
    Robert, M., Truchet, P., Veyrat, A.: Acidose lactique chez une diabétique traitée par le N,N-dimethylbiguanide. Lyon Med.229, 1143–1146 (1973)Google Scholar
  126. 126.
    Robin, E.D.: Dynamic aspects of metabolic acid base disturbances: Phenformin lactic acidosis with alkaline overshoot. Trans. Assoc. Am. Physicians85, 317–324 (1972)PubMedGoogle Scholar
  127. 127.
    Romankiewicz, J.A.: Phenformin-associated lactic acidosis: a review. Am. J. Hosp. Pharm.32, 502–507 (1975)PubMedGoogle Scholar
  128. 128.
    Salky, N., Hatch, F.E.: Lactic acidosis in diabetics treated with phenformin (DBI). J. Tenn. Med. Assoc.61, 879–881 (1968)PubMedGoogle Scholar
  129. 129.
    Schaffalitzky de Muckadell, O.B., Køster, A., Jensen, S.L.: Fenformin-alkohol-interaktion: Maelkesyreacidose og hypoglykaemi hos patienter med stabil diabetes mellitus. Ugeskr. Laeger.135, 925–927 (1973)PubMedGoogle Scholar
  130. 130.
    Selroos, O., Pasternack, A., Kuhlbäck, B.: Laktatacidos och fenformin. Ett fall framgangsrikt behandlat med hemodialys. Nord. Med.80, 1658–1661 (1968)PubMedGoogle Scholar
  131. 131.
    Sheppard, J.M., Lawrence, J.R., Oon, R.C.S., Thomas, D.W., Row, P.G., Wise, P.H.: Lactic acidosis: Recovery associated with use of peritoneal dialysis. Aust. NZ. J. Med.1972 IV, 389–392Google Scholar
  132. 132.
    Shirriffs, G.G., Bewsher, P.D.: Hypothermia, abdominal pain, and lactic acidosis in phenformin-treated diabetic. Br. Med. J.1970 III, 506Google Scholar
  133. 133.
    Simpson, I.J., Henley, J.W., Sharpe, D.N.: Lactic acidosis associated with phenformin therapy in diabetes mellitus. NZ. Med. J.79, 645–648 (1974)Google Scholar
  134. 134.
    Sproule, B.J., Phillipson, E.A., Couves, C.M., Brownlee, R.T.: Acute pulmonary hypertension in idiopathic lactic acidosis. Can. Med. Assoc. J.94, 141–143 (1966)PubMedGoogle Scholar
  135. 135.
    Strandgaard, S.: Svaer metabolisk acidose hos diabetiker i behandling med fenformin og allopurinol. En folge af medikamentel interaktion? Ugeskr. Laeger.132, 1834–1836 (1970)PubMedGoogle Scholar
  136. 136.
    Strauss, F.G., Sullivan, M.A.: Phenformin intoxication resulting in lactic acidosis. Johns Hopkins Med. J.128, 278–281 (1971)PubMedGoogle Scholar
  137. 137.
    Strohmeyer, G., Dölle, W., Sauer, H.: Milchsäureacidose mit Excesslactat bei Diabetes mellitus. Dtsch. Med. Wochenschr.90, 2238–2240 (1965)PubMedGoogle Scholar
  138. 138.
    Talke, H., Maier, K.P., Scholz, H., Jontofsohn, R.: Zur Therapie der biguanidinduzierten Laktatazidose. Verh. Dtsch. Ges. Inn. Med.81, 704–705 (1975)PubMedGoogle Scholar
  139. 139.
    Talke, H., Scholz, H., Jontofsohn, R., Maier, K.P.: Laktatazidose während Phenformintherapie. Erfolgreiche Behandlung durch Hämodialyse und Bikarbonatinfusion. Therapiewoche24, 6124–6127 (1974)Google Scholar
  140. 140.
    Talke, H., Scholz, H., Jontofsohn, R., Maier, K.P.: Laktatazidose während Phenformin-Therapie. Erfolgreiche Behandlung durch Hämodialyse und Bicarbonatinfusion. Inn. Med.2, 80–85 (1974)Google Scholar
  141. 141.
    Tashima, C.K.: Phenformin, tetracycline, and lactic acidosis. Br. Med. J.1971 IV, 557–558Google Scholar
  142. 142.
    Tashima, C.K.: Hypoglycemia and probable lactic acidosis during phenformin therapy. Hawaii Med. J.32, 332–334 (1973)PubMedGoogle Scholar
  143. 143.
    Thimme, W., Buschmann, H.-J., Dissmann, W., Amft, R.: Biguanidtherapie und Lactatacidose. Med. Klin.71, 1429–1433 (1976)PubMedGoogle Scholar
  144. 144.
    Tilling, W., Stein, G.: Lactatacidose. Dtsch. Med. Wochenschr.95, 2336–2339 (1970)PubMedGoogle Scholar
  145. 145.
    Tomkins, A.M., Jones, R., Bloom, A.: Lactic acidosis occurring during phenformin therapy. Postgrad. Med. J.48, 386–387 (1972)PubMedGoogle Scholar
  146. 146.
    Tranquada, R.E., Bernstein, S., Grant, W.J.: Intravenous methylene blue in the therapy of lactic acidosis. Arch. Intern. Med.114, 13–25 (1964)PubMedGoogle Scholar
  147. 147.
    Tranquada, R.E., Bernstein, S., Martin, H.E.: Irreversible lactic acidosis associated with phenformin therapy. JAMA184, 37–42 (1963)PubMedGoogle Scholar
  148. 148.
    Tugaye, A., Rendu, Ch., Deuil, R.: Coma avec acidose lactique chez une diabétique traitée par le phénéthylbiguanide. Cah. Coll. Med. Hop. Paris9, 1055–1057 (1968)PubMedGoogle Scholar
  149. 149.
    Vinik, A.I., Jackson, W.P.U.: Lactic acidosis in diabetics. S. Afr. Med. J.48, 2021–2026 (1974)PubMedGoogle Scholar
  150. 150.
    Walker, R.S.: Lactic acidosis through medicaments. Helv. Med. Acta35, 448–455 (1969/70)Google Scholar
  151. 151.
    Walker, R.S., Hannah, R.: Experiences with phenformin (a two-year study). Diabetes10, 275–279 (1961)PubMedGoogle Scholar
  152. 152.
    Wegner, B., Muche, J.: Laktatazidose unter Buformin-Therapie. Dtsch. Gesundh.-Wesen32, 1040–1044 (1977)Google Scholar
  153. 153.
    Westervelt, F.B., jr., Owen, J.A., jr., Hornbaker, J.H., jr., Gorsuch, T.L.: Lactic acidosis: a case treated with THAM and hemodialysis. Va. Med. Mon.93, 251–256 (1966)PubMedGoogle Scholar
  154. 154.
    Westervelt, F.B., jr., Owen, J.A.,., Hornbaker, J.H., jr., Rhodes, A.G.: Severe lactic acidosis successfully treated with THAM and hemodialysis. Clin. Res. Proc.13, 55 (1965)Google Scholar
  155. 155.
    Williams, D.N., Knight, A.H., Goldberg, D.M.: Lactic acidosis and hyperamylasaemia associated with phenformin therapy. Postgrad. Med. J.50, 765–766 (1974)Google Scholar
  156. 156.
    Williamson, M.: Lactic acidosis: Report of case and review of literature. J. Am. Osteopath. Assoc.75, 803–819 (1976)PubMedGoogle Scholar
  157. 157.
    Wise, P.H., Chapman, M., Thomas, D.W., Clarkson, A.R., Harding, P.E., Edwards, J.B.: Phenformin and lactic acidosis. Br. Med. J.1976 I, 70–72Google Scholar
  158. 158.
    Wittmann, P., Haslbeck, M., Bachmann, W., Mehnert, H.: Lactacidosen bei Diabetikern unter Biguanidbehandlung. Dtsch. Med. Wochenschr.102, 5–10 (1977)PubMedGoogle Scholar
  159. 159.
    Young, J.M., Armanino, L.P.: Lactic acidosis and phenformin intoxication. Report of two cases with review of literature. Calif. Med.103, 198–202 (1965)PubMedGoogle Scholar
  160. 160.
    Alberti, K.G.M.M., Nattrass, M.: Lactic acidosis. Lancet1977 II, 25–29Google Scholar
  161. 161.
    Wittmann, P., Haslbeck, M., Bachmann, W., Mehnert, H.: Verlauf und Therapie bei Diabetikern mit Lactacidosen nach Biguanidbehandlung: Klinische Konsequenzen. Vortrag Nr. 69. 12. Kongreß der Deutschen Diabetesgesellschaft, Homburg/Saar 1977Google Scholar
  162. 162.
    Panzram, G.: Epidemiologie des Coma diabeticum. Schweiz. Med. Wochenschr.103, 203–208 (1973)PubMedGoogle Scholar
  163. 163.
    Beigelman, P.M.: Severe diabetic ketoacidosis (diabetic “coma”). 482 episodes in 257 patients: experience of three years. Diabetes20, 490–500 (1971)PubMedGoogle Scholar
  164. 164.
    Keller, U., Berger, W., Ritz, R., Truog, P.: Course and prognosis of 86 episodes of diabetic coma. Diabetologia11, 93–100 (1975)PubMedGoogle Scholar
  165. 165.
    Prachar, H., Bruneder, H., Nobis, H., Korp, W.: Coma diabeticum. Bericht über 752 Fälle (1931–1973). Munch. Med. Wochenschr.117, 661–668 (1975)Google Scholar
  166. 166.
    Isnard, F., Lavieuville, M.: Acidose lactique et biguanides: Etat actuel de la question en France. Journ. Annu. Diabetol. Hotel Dieu18, 362–375 (1977)Google Scholar
  167. 167.
    Berger, W.: Discussion remark. 12. Kongreß der Deutschen Diabetesgesellschaft, Homburg/Saar 1977Google Scholar
  168. 168.
    Harding, A.P.: Lactic acidosis and biguanides. NZ. Med. J.80, 31 (1974)Google Scholar
  169. 169.
    Freeman, H., Campbell, D.: Therapy of lactic acidosis. N. Engl. J. Med.292, 263–264 (1975)PubMedGoogle Scholar
  170. 170.
    Eggstein, M.: Zur Regulation des Serumneutralfettes und seiner Spaltprodukte und von Glukose, Laktat und Pyruvat im Blut. Verh. Dtsch. Ges. Inn. Med.71, 476–479 (1965)PubMedGoogle Scholar
  171. 171.
    Eggstein, M., Knödel, W.: Kohlenhydrat- und Fettstoffwechselprodukte im Blut nach Insulin und Rastinon. Verh. Dtsch. Ges. Inn. Med.72, 754–757 (1966)Google Scholar
  172. 172.
    Vinik, A. L., Jackson, W.P.U.: Lactic acidosis in diabetics. S. Afr. Med. J.49, 301 (1975)Google Scholar
  173. 173.
    Kreisberg, R.A., Owen, W.C., Siegal, A.M.: Hyperlacticacidemia in man: ethanol-phenformin synergism. J. Clin. Endocrinol. Metab.34, 29–35 (1972)PubMedGoogle Scholar
  174. 174.
    Spaethe, R., Hrstka, V., Schmidt, F.H., Otto, H.: Verlauf von Plasmalactat und Serum-Phenformin bei Diabetikern während einer kontrollierten Studie mit steigenden Phenformindosen, Vortrag Nr. 62. 12. Kongreß der Deutschen Diabetesgesellschaft, Homburg/Saar 1977Google Scholar
  175. 175.
    Williams, R.H., Palmer, J.P.: Farewell to phenformin for treating diabetes mellitus. Ann. Intern. Med.83, 567–568 (1975)PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • D. Luft
    • 1
  • R. M. Schmülling
    • 1
  • M. Eggstein
    • 1
  1. 1.Medizinische KlinikEberhard-Karls-UniversitätTübingenFRG

Personalised recommendations